Aktive Wirkstoffe
- nateglinide
- necitumumab
- Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis
- Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis
- Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily A
- Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily B
- nelarabine
- nelfinavir
- nepafenac
- neratinib
- Netarsudil
- netupitant, palonosetron hydrochloride
- nevirapine
- nilotinib
- nintedanib
- Niraparib (tosilate monohydrate)
- nitisinone
- Nitric oxide
- nivolumab
- Nomegestrol acetate, estradiol